Vascular endothelium summary statement VI: Research directions for the 21st century

被引:5
作者
Mensah, George A.
Catravas, John D.
Engelgau, Michael M.
Hooper, W. Craig
Madeddu, Paolo
Ryan, Una S.
She, Jin-Xiong
Reed, Eddie
Vinicor, Frank
Yacoub, Magdi H.
机构
[1] Ctr Dis Control & Prevent, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA 30341 USA
[2] Med Coll Georgia, Vasc Biol Ctr, Augusta, GA 30912 USA
[3] Ctr Dis Control & Prevent, Natl Ctr Birth Defects & Dev Disabil, Atlanta, GA USA
[4] Univ Bristol, Bristol Heart Inst, Bristol, Avon, England
[5] AVANT Immunotherapeut, Needham, MA USA
[6] Med Coll Augusta, Ctr Biotechnol & Genom Med, Augusta, GA USA
[7] Harefield Hosp, Imperial Coll Sch Med, Heart Sci Ctr, Harefield UB9 6JH, Middx, England
关键词
endothelium; research translation; prevention;
D O I
10.1016/j.vph.2006.10.016
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Effective translation of research advances from the bench to clinical and public health practice at the bedside and in the community at large represents an important step in the health research discovery enterprise. Increasingly,, the gap in translating these advances into practice is being recognized. Successfully addressing this translational gap for the prevention and control of chronic diseases will require the development of novel, innovative, and, if necessary, nontraditional approaches. Participants in the 8th International Conference on Vascular Endothelium discussed a variety of novel approaches that have significant promise. Three of these approaches-vaccine development, genomics and proteomics, and tissue engineering-are highlighted in this position statement and strategies for public health practice and research are suggested. (c) 2007 Published by Elsevier Inc.
引用
收藏
页码:330 / 332
页数:3
相关论文
共 18 条
[1]   Challenges for public health in the global context - prevention and surveillance [J].
Beaglehole, R ;
Bonita, R .
SCANDINAVIAN JOURNAL OF PUBLIC HEALTH, 2001, 29 (02) :81-83
[2]   Progress on new vaccine strategies for the immunotherapy and prevention of cancer [J].
Berzofsky, JA ;
Terabe, M ;
Oh, SK ;
Belyakov, IM ;
Ahlers, JD ;
Janik, JE ;
Morris, JC .
JOURNAL OF CLINICAL INVESTIGATION, 2004, 113 (11) :1515-1525
[3]  
Bitton RJ, 2004, CURR OPIN MOL THER, V6, P17
[4]   European Public Health Association [J].
Brundtland, GH .
EUROPEAN JOURNAL OF PUBLIC HEALTH, 2005, 15 (01) :3-5
[5]   The safety and immunogenicity of a CETP vaccine in healthy adults [J].
Davidson, MH ;
Maki, K ;
Umporowicz, D ;
Wheeler, A ;
Rittershaus, C ;
Ryan, U .
ATHEROSCLEROSIS, 2003, 169 (01) :113-120
[6]   Public health in the twentieth century: Advances and challenges [J].
Fielding, JE .
ANNUAL REVIEW OF PUBLIC HEALTH, 1999, 20 :XIII-XXX
[7]  
Fielding JE, 2002, J LAW MED ETHICS, V30, P22
[8]  
Institute of Medicine (US) Committee on Assuring the Health of the Public in the 21st Century, 2003, FUT PUBL HLTH 21 CEN
[9]  
Khoury Muin J, 2005, Prev Chronic Dis, V2, pA05
[10]   Global epidemiology and public health in the 21st century - Applications of new technology [J].
LaPorte, RE ;
Barinas, E ;
Chang, YF ;
Libman, I .
ANNALS OF EPIDEMIOLOGY, 1996, 6 (02) :162-167